(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 4.78% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Revvity's revenue in 2025 is $2,755,026,000.On average, 5 Wall Street analysts forecast RVTY's revenue for 2025 to be $340,102,857,053, with the lowest RVTY revenue forecast at $339,246,642,828, and the highest RVTY revenue forecast at $340,900,419,883. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $361,586,815,175, with the lowest RVTY revenue forecast at $358,831,161,082, and the highest RVTY revenue forecast at $364,010,031,235.
In 2027, RVTY is forecast to generate $391,074,405,233 in revenue, with the lowest revenue forecast at $391,013,710,654 and the highest revenue forecast at $391,135,099,813.